SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

Overview of attention for article published in Frontiers in Public Health, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,114 followers.

@agingdoc1 That is interesting! I was basing my assumption on this, which shows no benefit over placebo: https://t.co/NcFZ75cgZR

25 Jan 2023

Reply Repost Favourite

New Research: SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials: Background: Currently, the association between sodium-glucose cotransporter 2 inhibitor (SGLT-2i) and malignancy… https://t.co/AnswysJMnf #Pub

07 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.